This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 9 from Patent US 20030077289
General Information
DCTPep ID DCTPep01236
Peptide Name Sequence 9 from Patent US 20030077289
Sequence PLSSIFSRIGDP
Sequence Length 12
PubChem CID Not available
Origin Hepatitis B virus
Type Native peptide
Classification
ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure Not available
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Not available
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification None
Chiral L
Physicochemical Information
Formula C58H93N15O18
Absent amino acids ACEHKMNQTVWY
Theoretical pI 6.27
Acidic residues 1
Basic residues 1
Polar residues 4
Molecular weight (Average) 1288.47
Molecular weight (Monoisotopic) 1287.68
Common amino acids S
Net charge 0
Instability index (II) 41.27
Aliphatic index 97.50
Grand average of hydropathicity (GRAVY) 0.133
Half Life
>20 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
? (Escherichia coli, in vivo).
Extinction coefficients
Should not be visible by UV spectrophotometry.
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2003/0077289 A1
Patent Title Use of cell-penetrating peptides to generate antitumor immunity.
Other Iinformation Granted Patent Family: 6s / 6ex; Family Jurisdictions: CN, WO, AU, US; Legal Status: Discontinued; Application No: 7755502; Filed:Feb 15, 2002; Published: Apr 24, 2003; Earliest Priority: Feb 15, 2001
Other Published ID CN1309417C CN1503628A WO2002064057A2 WO2002064057A3
This work is licensed under a Creative Commons Attribution 4.0 International License.